Error: Could not add to watchlist. X

Harel 4B Selected Biomed

+ Watchlist
IL30EQY:IT
2,856.94
ILs
42.90
1.48%
As of 00:59:30 ET on 07/02/2015.
Volume
0
Previous Close
2,899.84
52Wk Range
2,540.33 - 3,774.26
1 Yr Return
-24.30%
Fund Type
-
Objective
-
Asset Class Focus
-
Geographic Focus
-
NAV (on 07/02/2015)
2,856.94
Total Assets (m ILs) (on 05/29/2015)
19.000
Inception Date
01/01/1993
Last Dividend (on -)
-
Dividend Indicated Gross Yield
-
Fund Managers
-
Front Load Fee
-
Back Load Fee
-
Redemption Fee
-
12b-1 Fee
-
Current Mgmt Fee
2.51%
Expense Ratio
2.94%
Top Fund Holdings
Name Position Value % of Fund
Evogene Ltd 56.27 k 1.97 m 9.46
Pluristem Therapeutics Inc 176.32 k 1.94 m 9.31
Compugen Ltd 63.00 k 1.82 m 8.73
Kamada Ltd 100.00 k 1.76 m 8.43
Clal Biotechnology Industries 320.00 k 1.71 m 8.18
Mazor Robotics Ltd 65.00 k 1.46 m 7.01
OPKO Health Inc 24.00 k 1.39 m 6.67
Protalix BioTherapeutics Inc 172.60 k 1.18 m 5.67
Brainsway Ltd 29.00 k 999.05 k 4.79
Elron Electronic Industries Lt 47.00 k 916.50 k 4.39
Profile
Harel 4B Selected Biomed is an open-end fund registered in Israel. The objective of the fund is to exceed to TA Biomed Index. The fund primarly invests in Biotechnology and Pharmaceutical equities.
ADDRESS
Ilanot Fund Management
PHONE
-
WEBSITE
-